4-cymene has been researched along with naphthoquinones in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biersack, B; Mahal, K; Schobert, R; Spoerlein-Guettler, C | 1 |
| Anderson, RF; Hartinger, CG; Jakupec, MA; Kandioller, W; Keppler, BK; Kim, K; Klapproth, E; Kubanik, M; Roller, A; Söhnel, T | 1 |
2 other study(ies) available for 4-cymene and naphthoquinones
| Article | Year |
|---|---|
Ferrocene and (arene)ruthenium(II) complexes of the natural anticancer naphthoquinone plumbagin with enhanced efficacy against resistant cancer cells and a genuine mode of action.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Coordination Complexes; Cymenes; DNA; Female; Ferrous Compounds; Humans; Metallocenes; Monoterpenes; Naphthoquinones; Ruthenium; Uterine Cervical Neoplasms | 2014 |
Towards targeting anticancer drugs: ruthenium(ii)-arene complexes with biologically active naphthoquinone-derived ligand systems.
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Line, Tumor; Cell Survival; Coordination Complexes; Cymenes; Drug Resistance, Neoplasm; Glutathione; Humans; Monoterpenes; Naphthoquinones; Ruthenium | 2016 |